Division of Infection, Immunity & Respiratory Medicine, UK
Research Article
Economic Evaluation of Subcutaneous Allergen Immunotherapy versus Symptomatic Treatment in Patients with Allergic Rhinitis with or without Asthma
Author(s): C. Mylonas*, N. Maniadakis, N. Kitsioulis, P. Xepapadaki and N. G. Papadopoulos
Introduction: Allergen immunotherapy (AIT) is a commonly treatment that decreases symptoms for people with allergic rhinitis (AR) and asthma (AA). Despite the wide use of AIT, the economic evaluation of AIT versus symptomatic treatment has not been well established.
Objective: To conduct a cost-effectiveness (CE) analysis of subcutaneous immunotherapy (SCIT) versus symptomatic treatment for AR and AA, in the Greek health care setting. The consequences of treatments were evaluated from a 3rdparty payer perspective in a 10-year time horizon.
Method: A Decision tree model was used to reflect the natural progression and evaluate the CE of the comparators. Efficacy and safety data considered in the model were extracted from literature review and published studies. Utilities values were extracted from the literature. Direct .. View More»
DOI:
10.35248/2471-268X.21.7.165
